Thyroid Cancer
📧 Sign up to get email alerts when something new happens for Thyroid Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-07-02Clinical Trial Results: Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health [NA]
Clinical trial results for adapting multiple behavior interventions to improve cancer survivor health; completed with results posted.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: 177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer [Phase 1, Phase 2]
A Phase 1/2 study evaluating the radiopharmaceutical 177Lu-DOTA-EB-TATE in adults with metastatic, radioactive iodine non-responsive Hurthle…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease [Phase 1]
Phase 1 trial evaluating bevacizumab and temsirolimus alone or with valproic acid or cetuximab in patients with advanced or metastatic malig…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Clinical and Genetic Studies in Familial Non-medullary Thyroid Cancer
This clinical trial update reports ongoing clinical and genetic studies in familial non-medullary thyroid cancer. Recruitment is currently o…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery [Phase 2]
Phase 2 neoadjuvant trial of Zanzalintinib for advanced thyroid cancer is enrolling before surgery.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations. [Phase 1]
Pfizer's PF-07799933 is being studied in a Phase 1 trial for advanced solid tumors with BRAF alterations. The study includes melanoma, non-s…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Comparison of I-124 PET/CT for the Diagnosis of Thyroid Cancer [Phase 2]
This document provides an update on a Phase 2 clinical trial evaluating Iodine-124 PET/CT imaging for diagnosing thyroid cancer, which is cu…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial of S241656 in RAS/MAPK mutation-positive malignancies is currently recruiting. The study targets non-small cell lun…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer [Phase 2]
The document details a Phase 2 clinical trial evaluating 68Ga-DOTATATE-PET/CT imaging for metastatic thyroid cancer. The trial is currently …
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Studies on Tumors of the Thyroid
National Institute of Diabetes and Digestive and Kidney Diseases is recruiting for thyroid tumor studies spanning multiple thyroid cancer su…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Integrating Tumor Genomics and Urinary Exosomal Proteomics to Establish a Multi-Layer Biomarker Framework for Early Risk Stratification and Post-Treatment Surveillance in Fresh Thyroid Cancer Patients
This clinical trial aims to integrate tumor genomics and urinary exosomal proteomics to develop a multi-layer biomarker framework for early …
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord [Phase 2]
This is a Phase 2 clinical trial update evaluating the combination of thermal ablation and spine stereotactic radiosurgery for spine metasta…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Follow up for Patients With Thyroid Cancer Planed for Radioiodine Scan or Treatment
Clinical trial update for thyroid cancer patients planned for radioiodine scan or treatment; the study is currently active but not recruitin…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Selumetinib and Olaparib in Solid Tumors [Phase 1]
Phase 1 trial evaluating the combination of selumetinib and olaparib in various solid tumors; the study is currently active but not recruiti…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma [Phase 1]
This is a Phase 1 clinical trial from Memorial Sloan Kettering Cancer Center evaluating lesion dosimetry using the radioactive tracer Iodine…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: New MRI Biomarkers in Head and Neck Cancers
Memorial Sloan Kettering Cancer Center is recruiting for a study evaluating new MRI biomarkers in head and neck cancers, including thyroid c…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Correlation Between Various Urinary Exosomal Protein Biomarkers and Pathological Manifestation in Thyroid Follicular Neoplasm: Early and Pre-operative Diagnosis of Follicular Thyroid Cancer
This clinical trial update investigates the correlation between urinary exosomal protein biomarkers and pathological manifestations in thyro…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Ganoderma Spores Modulate the Gut-Brain Axis [NA]
A not-yet-recruiting clinical trial is evaluating Ganoderma spores as a potential modulator of the gut-brain axis in depression and thyroid …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Urinary Exosomal Biomarkers of Thyroglobulin and Galectin-3 for Prognosis and Follow-up in Patients of Thyroid Cancer
A clinical trial update for a study assessing urinary exosomal biomarkers (thyroglobulin and galectin-3) to predict prognosis and monitor th…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: An Observational Study on Postoperative Symptoms After Thyroidectomy (POS-T)
Observational study evaluating postoperative symptoms after thyroidectomy in thyroid cancer patients; currently recruiting at Ilsan Cha hosp…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Study of Avutometinib and Defactinib in People With Thyroid Cancer [Phase 2]
A Phase 2 clinical trial is evaluating the combination of Avutometinib and Defactinib for thyroid cancer, with recruitment ongoing.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Identification and Differentiation of Thyroid Nodules by Acoustic Imaging and Viscoelastic Parameters
Mayo Clinic is conducting a clinical trial to identify and differentiate thyroid nodules using acoustic imaging and viscoelastic parameters,…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors [Phase 1]
A Phase 1 trial evaluating donor natural killer cells with cyclophosphamide and etoposide in children and young adults with relapsed or refr…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Pembrolizumab With Chemotherapy for Poorly Chemo-responsive Thyroid and Salivary Gland Tumors [Phase 2]
A Phase 2 clinical trial evaluating pembrolizumab combined with chemotherapy for poorly chemo-responsive thyroid and salivary gland cancers …
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Global Real World Data in Patients With Advanced Thyroid Cancer on Standard of Care and Specialized Interventions- Registry of Oncologic Outcomes With Testing and Treatment.
A registry study collecting real-world outcomes for patients with advanced thyroid cancer receiving standard of care plus specialized interv…